First-Line Treatment of Convulsive Status Epilepticus
Clinical scenario
Status epilepticus is a time-critical neurological emergency. Management must begin at 5 minutes of seizure duration. By the 20-minute mark, response to initial therapy must be apparent and the next clinical decision made.
Initial treatment approach
The recommended first-line intervention is a benzodiazepine — the agent class supported by the strongest evidence for efficacy, safety, and tolerability. Established alternatives are available for prehospital settings and circumstances where standard first-line options cannot be used. The specific agents, routes, dosing strategy, sequencing, and full algorithm are detailed in the complete protocol…
Clinical goal
The primary therapeutic target is:
Termination of convulsive status epilepticus by the 20-minute mark
References
DOI: 10.5698/1535-7597-16.1.48
- The initial therapy phase should begin when the seizure duration reaches 5 minutes and should conclude by the 20-minute mark when response (or lack of response) to initial therapy should be apparent.
- A benzodiazepine (specifically IM midazolam, IV lorazepam, or IV diazepam) is recommended as the initial therapy of choice, given their demonstrated efficacy, safety, and tolerability (level A, four class I RCTs).
- For prehospital settings or where the three first-line benzodiazepine options are not available, rectal diazepam, intranasal midazolam, and buccal midazolam are reasonable initial therapy alternatives (level B).
- Initial therapy should be administered as an adequate single full dose rather than broken into multiple smaller doses.
View source ↗